Jeff Caravella joined Tango Therapeutics as vice president of Finance in January 2019. Jeff’s experience spans a wide range of strategic, business development and operating finance roles in the healthcare and life sciences industry. Most recently, Jeff served as the senior director of finance at Editas Medicine. Prior to joining Editas, Jeff was the head of financial operations for the global discovery and research models & services divisions at Charles River Laboratories. Prior to that, he held several positions for over a decade at Johnson & Johnson, with finance responsibilities that spanned the commercial, business development and manufacturing areas.
Jeff earned both his Master of Business Administration and Bachelor of Science from Syracuse University and also holds a Financial Planning and Analysis (FP&A) certification.